Department of Health

Blood Matters program

The Blood Matters Program is a Victorian Government Program run in collaboration with the Australian Red Cross Lifeblood

Banner image for Blood Matters Program

The Blood Matters program is underpinned by the Department’s values, vision, and priorities. Read more about the priorities on the Our priorities page.

The program aims to support best practice in all areas related to blood management safety and governance.

The content of these pages is intended for use by health care staff; clinical, quality, and scientific.

What's new

  • An information page for patients explaining the change from Intragam 10 to Privigen Au. Visit the Blood matters consumer information page.

  • The 2023 Blood Matters audit is the appropriate use of fresh frozen plasma (FFP)

    The audit assess the appropriate use of FFP in accordance with the following:

    The audit instructions and a data collection tool can be found on the Blood Matters audits page.

  • The STIR Bulletin on blood product checking is now available on the Serious Transfusion Incident Reporting system page.

  • To align Victoria with the National Statement for the Emergency Use of Group O Red Blood Cells (RBC)External Link , Blood Matters have worked with Safer Care Victoria for endorsement, education, and promotion of the appropriate utilisation of emergency use group O RBC. Further information, including resources and support tools for download are available on the Emergency use of group O red blood cells page.

  • The manufacturing process for five of Australia’s domestic plasma products will change.

    The first product change is Intragam® 10, it will soon be discontinued and Privigen® AU will be available in its place.

    The intravenous immunoglobulin presentation and guidance documents have been updated to reflect this change and can be found on the IVIg changes to supply and governance page.

    The products will continue to be manufactured in Australia from Australia’s plasma, but will be manufactured using CSL Behring’s global manufacturing processes.

    As per the current products, the transitioned products will comply with the safety and efficacy requirements set by the Therapeutic Goods Administration. For more information visit the National Blood AuthorityExternal Link website.

  • The Blood transfusion consent audit report is now available to download from the Blood Matters - audit reports page.

    The blood transfusion consent audit was conducted in 2 parts in 2022:

    • Part A was a consent policy review
    • Part B was retrospective medical record audit of up to 30 patients who had received a blood component transfusion.

Reviewed 16 May 2023


Contact us

Blood Matters Program Australian Red Cross Lifeblood

Was this page helpful?